| Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial 2021 · AA:DHA group · Extremely preterm infants born before 28 weeks’ gestational age | 100 mg/kg | 92 days | 101 |
| Platelet characteristics in extremely preterm infants after fatty acid supplementation: a randomized controlled trial 2025 · AA/DHA supplement · Extremely preterm infants born before 28 weeks’ gestational age | 100 mg/kg | — | 84 |
| Enteral supplementation with arachidonic and docosahexaenoic acid and pulmonary outcome in extremely preterm infants 2024 · AA and DHA supplementation · Extremely preterm infants | 100 mg/kg | — | — |
| Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis 2004 · arachidonic acid (AA) · Patients with advanced cirrhosis; age and sex not reported | 4 g | 8 weeks | — |
| Docosahexaenoic Acid and Arachidonic Acid Supplementation and Sleep in Toddlers Born Preterm: Secondary Analysis of a Randomized Clinical Trial 2019 · DHA+AA supplementation · Children aged 10 to 16 months at enrollment, born before 35 weeks' gestation | 200 mg | 180 days | 193 |
| Fatty Acid Supplementation and Socioemotional Outcomes: Secondary Analysis of a Randomized Trial 2020 · DHA + AA · Children aged 10 to 16 months at enrollment, born at less than 35 weeks' gestation | 200 mg | 180 days | 161 |
| Evaluation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) in a randomised controlled trial aiming for prevention of severe ROP: a substudy of the Mega Donna Mega trial 2022 · AA:DHA · Infants born before 28 weeks of gestational age | 100 mg/kg | — | 84 |
| Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial 2017 · DHA/ARA supplement group · Healthy term-born toddlers enrolled at 12–14 months of age | 200 mg | 1 year | 68 |
| Long-chain Polyunsaturated Fatty Acid Supplementation Improves Mood in Elderly Japanese Men 2017 · LCPUFA group · Japanese men aged 55–64 years | 120 mg | 4 weeks | 51 |
| Effects of combining exercise with long-chain polyunsaturated fatty acid supplementation on cognitive function in the elderly: a randomised controlled trial 2020 · Ex + LCPUFA · Japanese adults aged 60–79 who were not exercising regularly, had age-related cognitive-decline complaints and lower memory scores, and did not have dementia; exercise arm participants had low skeletal muscle mass in the reported subgroup analysis | 120 mg | 24 weeks | 21 |
| Low Doses of Long-chain Polyunsaturated Fatty Acids Affect Cognitive Function in Elderly Japanese Men: A Randomized Controlled Trial 2015 · LCPUFA group · Japanese men aged 55–64 years without dementia | 120 mg | 4 weeks | — |
| Effect of arachidonic and docosahexaenoic acid supplementation on respiratory outcomes and neonatal morbidities in preterm infants 2023 · intervention · Very preterm infants with gestational age less than 29 weeks | 100 mg/kg | — | — |
| Effect of arachidonic and docosahexaenoic acid supplementation on quality of growth in preterm infants: A secondary analysis of a randomized controlled trial 2023 · ARA:DHA group · Infants born before 29 weeks of gestation | 100 mg/kg | — | — |
| Effect of small-quantity lipid-based nutrient supplements on growth, psychomotor development, iron status, and morbidity among 6- to 12-mo-old infants in South Africa: a randomized controlled trial 2019 · SQ-LNS-plus · Infants enrolled at 6 months of age in a peri-urban South African setting; no specific disease or deficiency was required. | 75 mg | 26 weeks | 250 |
| Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults 2023 · LCPUFAs + LZ group, Trial 2 · Healthy Japanese adults aged 55–79 with memory complaints and no dementia; cognitive-decline subgroup had MoCA-J scores below 23 | 120 mg | 12 weeks | 96 |
| Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults 2023 · LCPUFAs + LZ group, Trial 1 · Healthy Japanese adults aged 55–79 with memory complaints and no dementia; cognitive-decline subgroup had MoCA-J scores below 23 | 120 mg | 24 weeks | 40 |
| EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors 2003 · PUFA supplement group · Children with ADHD-like symptoms who also reported thirst and skin problems; age and sex not stated | 40 mg | 120 days | 25 |
| Low-dose arachidonic acid intake increases erythrocytes and plasma arachidonic acid in young women 2010 · arachidonic acid supplementation · young Japanese women | 80 mg | 3 weeks | 23 |
| Arachidonic acid supplementation modulates blood and skeletal muscle lipid profile with no effect on basal inflammation in resistance exercise trained men 2018 · arachidonic acid supplementation · Resistance-trained men aged 24 ± 1.5 years, with at least 1 year of resistance training | 1.5 g | 4 weeks | 9 |
| Effects of arachidonate-enriched triacylglycerol supplementation on serum fatty acids and platelet aggregation in healthy male subjects with a fish diet 2007 · ARA group · Healthy Japanese men consuming a fish diet | 838 mg | 6 weeks | — |
| Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals: a randomized controlled study 2011 · Low-ARA group · Healthy men and women aged 55–70 years living in Tokyo and its environs | 240 mg | 4 weeks | 22 |
| Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals: a randomized controlled study 2011 · High-ARA group · Healthy men and women aged 55–70 years living in Tokyo and its environs | 720 mg | 4 weeks | 22 |
| Arachidonic acid supplementation transiently augments the acute inflammatory response to resistance exercise in trained men 2018 · ARA supplementation · Previously trained men, ages 24 ± 1.5 years | 1.5 g | 4 weeks | 9 |
| Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y 2001 · AA group · Healthy adults aged 55–75 years | 680 mg | 12 weeks | — |
| Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans 2001 · ARA group · Healthy adults aged 55–75 years | 680 mg | 12 weeks | — |
| Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults 2001 · ARA · Healthy adults aged 55–75 years | 700 mg | 12 weeks | — |
| Influence of low-dose polyunsaturated fatty acids supplementation on the inflammatory response of healthy adults 2007 · group B (inflammatory fat blend) · healthy adult volunteers | 40 mg | 2 weeks | — |
| Effect of dietary arachidonic acid supplementation on acute muscle adaptive responses to resistance exercise in trained men: a randomized controlled trial 2018 · ARA · Resistance-trained men with at least 1 year of resistance-training experience | 1.5 g | 4 weeks | — |
| The effect of supplementation with docosahexaenoic and arachidonic acid derived from single cell oils on plasma and erythrocyte fatty acids of pregnant women in the second trimester 2000 · intervention group · Healthy pregnant women in the second trimester | 260 mg | 4 weeks | 12 |
| Plasma fatty acid responses, metabolic effects, and safety of microalgal and fungal oils rich in arachidonic and docosahexaenoic acids in healthy adults 1996 · 1 x · healthy adult men | 800 mg | 2 weeks | 8 |
| Plasma fatty acid responses, metabolic effects, and safety of microalgal and fungal oils rich in arachidonic and docosahexaenoic acids in healthy adults 1996 · 3 x · healthy adult men | 2.2 g | 2 weeks | 8 |
| Plasma fatty acid responses, metabolic effects, and safety of microalgal and fungal oils rich in arachidonic and docosahexaenoic acids in healthy adults 1996 · 5 x · healthy adult men | 3.6 g | 2 weeks | 8 |
| Supplementation of arachidonic acid plus docosahexaenoic acid in cirrhotic patients awaiting liver transplantation: a preliminary study 2007 · AA/DHA group · Adults with end-stage liver disease awaiting liver transplantation | 500 mg | 6 weeks | 5 |
| Human milk arachidonic acid and docosahexaenoic acid contents increase following supplementation during pregnancy and lactation 2009 · AA+DHA · Women supplemented during pregnancy and lactation | 220 mg | — | — |
| Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid: A secondary analysis of the Mega Donna Mega trial 2023 · AA:DHA supplementation group · Extremely preterm infants born before 28 weeks’ gestation | 100 mg/kg | — | — |
| Proteomic Profile in Retinopathy of Prematurity: A Secondary Analysis of the Mega Donna Mega Randomized Clinical Trial 2026 · AA/DHA supplementation · Extremely preterm infants born before 28 weeks’ gestational age | 100 mg/kg | — | 84 |
| Essential Fatty Acid Supplementation and Early Inflammation in Preterm Infants: Secondary Analysis of a Randomized Clinical Trial 2023 · ARA:DHA group · Extremely preterm infants born at gestational age less than 29 weeks | 100 mg/kg | — | 60 |
| Arachidonic and docosahexaenoic acid supplementation and brain maturation in preterm infants; a double blind RCT 2024 · ARA:DHA group · Infants born before 29 weeks gestational age | 100 mg/kg | — | 60 |
| Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation 2011 · fish oil · Men with newly diagnosed, favorable-risk prostate cancer on active surveillance | 1.1 g | 90 days | 27 |
| Urinary metabolite profiles in premature infants show early postnatal metabolic adaptation and maturation 2014 · intervention group · Premature infants with birth weight below 1500 g | 60 mg/kg | 4 weeks | 24 |
| Fatty acid absorption in preterms on formulas with and without long-chain polyunsaturated fatty acids and in terms on formulas without these added 2001 · Group PB · Preterm newborns receiving preterm formula supplemented with arachidonic acid and docosahexaenoic acid | 17 mg/kg | 3 days | 13 |
| Arachidonic acid and docosahexaenoic acid supplementation increases coronary flow velocity reserve in Japanese elderly individuals 2008 · PUFA · Japanese elderly individuals, mean age 65 years; no condition stated | 240 mg | 90 days | — |